Analyst Price Target is $353.33
▲ +75.70% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Medifast in the last 3 months. The average price target is $353.33, with a high forecast of $400.00 and a low forecast of $265.00. The average price target represents a 75.70% upside from the last price of $201.10.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in Medifast. This Buy consensus rating has held steady for over two years.